Shopping Cart
- Remove All
- Your shopping cart is currently empty
L-798106 (CM9) is a selective and potent prostaglandin-like EP3 receptor antagonist that inhibits EP4, EP1, and EP2 receptors, suppresses levels of pro-inflammatory cytokines in atherosclerosis, and attenuates PGE2-induced cough.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $41 | In Stock | |
5 mg | $106 | In Stock | |
10 mg | $168 | In Stock | |
25 mg | $347 | In Stock | |
50 mg | $558 | In Stock | |
100 mg | $893 | In Stock | |
200 mg | $1,180 | In Stock |
Description | L-798106 (CM9) is a selective and potent prostaglandin-like EP3 receptor antagonist that inhibits EP4, EP1, and EP2 receptors, suppresses levels of pro-inflammatory cytokines in atherosclerosis, and attenuates PGE2-induced cough. |
Targets&IC50 | EP3 receptor: 0.3 nM(ki), EP4 receptor:916 nM(ki), EP4 receptor:916 nM(Ki), EP1/2 receptor:> 5000 nM(ki), EP3 receptor:0.3 nM(Ki), EP1/2 receptor:> 5000 nM(Ki) |
In vitro | In the guinea-pig vas deferens, L-798106 (200 nM) showed an apparent pA2 of 7.48±0.25[2]. |
In vivo | In male db/db mice, L-798106 (50 and 100 μg/kg; oral gavage; once daily; 8 weeks) suppressed the increased fasting blood glucose levels and inhibited the increased proinflammatory gene expressions in adipocytes isolated from epididymal adipose tissue of db/db mice[3]. |
Alias | L 798106, GW-671021, GW671021, CM-9, CM9 |
Molecular Weight | 536.44 |
Formula | C27H22BrNO4S |
Cas No. | 244101-02-8 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
Solubility Information | DMSO: 5 mg/mL (9.32 mM), Sonication is recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.